Development of biofluid-based tests for cancer is an exciting area of innovation that is being enabled by powerful genomic technologies such as digital PCR. These new tests have the potential to dramatically improve tumor characterization and the real-time monitoring of cancer in a mi
The Team behind RainDrop™ Digital PCR System Here at RainDance Technologies, we’re fortunate to have a first-rate team of scientists and business people — they are truly the heart of our company. In a series of blog posts, we’ll be profiling some of our team members to give you a glim
A good nosh. The webinar time slot, 11:30 am EDT, makes it a universally friendly time to munch and watch. You can have breakfast on the West Coast, lunch on the East Coast, dinner in Europe, or a midnight snack in Asia. Cutting-edge information. If the last new thing you learned abou
Abstract Digital PCR is poised to make a significant impact on disease research and the development of molecular diagnostics. Its ability to precisely analyze nucleic acids at a molecular level makes it ideal for tasks such as detecting copy number variation and point mutations. In th
Next week, people from around the world will descend on Washington, D.C. for the annual meeting of the American Association for Cancer Research to hear about the latest discoveries in basic science, translational research, clinical trials, and population studies. Under the banner of t
Participants get first access to game-changing platform for low frequency allele detection using their own samples LEXINGTON, Mass. – July 26, 2012 – RainDance Technologies, Inc., the Digital Biology™ Company, today announced that it has begun accepting biological samples from p
Attendees of annual European Human Genetics Meeting have opportunity to see innovative RainDrop System up close LEXINGTON, Mass. AND NUREMBERG, Germany, June 25, 2012 – RainDance Technologies, Inc., the Digital Biology™ Company, today announced the introduction of its new RainDrop™ Di
RainDance Technologies® is making complex genetics simple. The company’s ultra-sensitive genomic tools enable research of novel non-invasive liquid biopsy applications that should result in more accurate, reliable, cost-effective, and early detection of cancer and other inherited and infectious diseases. Major research institutions and laboratories around the world rely on the performance of RainDance systems. Based outside Boston, Massachusetts, the company supports customers using RainDrop® Digital PCR, as well as the ThunderStorm® and ThunderBolts™ Next-Generation Sequencing Enrichment Systems through its international sales and service operations, as well as a global network of distributors and commercial service providers. Both technology platforms have been recognized by The Scientist as Top 10 Innovations with the RainDrop System winning the award in 2014 and the ThunderStorm System winning the award in 2011.